LPL Financial’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-65,500
Closed -$3.39M 5299
2024
Q3
$3.39M Sell
65,500
-6,000
-8% -$281K ﹤0.01% 2272
2024
Q2
$2.97M Buy
71,500
+71,255
+29,084% +$3.19M ﹤0.01% 2268
2024
Q1
$1.33M Buy
+245
New +$12.5K ﹤0.01% 2930

Other funds holding BMY

LPL Financial's BMY Position: Q1 2026 in Review

LPL Financial increased its Bristol-Myers Squibb (BMY) stake by 13% in Q1 2026, buying an estimated $20.9M and bringing the position to 3,212,769 shares worth $195M. The position accounts for 0.05% of the portfolio, ranked #348.

LPL Financial first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $199M in Q1 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • LPL Financial held 3,212,769 shares of Bristol-Myers Squibb worth $195M as of Q1 2026.
  • LPL Financial bought 359,262 Bristol-Myers Squibb shares in Q1 2026, an estimated $20.9M.
  • Bristol-Myers Squibb made up 0.05% of LPL Financial's portfolio in Q1 2026, its #348 holding.
  • LPL Financial first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • LPL Financial's Bristol-Myers Squibb position peaked at $199M in Q1 2025.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.